KPTI
Karyopharm Therapeutics Inc.
Company Overview
| Mkt Cap | $54.89M | Price | $5.80 |
| Volume | 167.93K | Change | -2.68% |
| P/E Ratio | -0.7 | Open | $5.97 |
| Revenue | $145.2M | Prev Close | $5.96 |
| Net Income | $-76.4M | 52W Range | $3.51 - $14.25 |
| Div Yield | N/A | Target | $15.67 |
| Overall | 33 | Value | 40 |
| Quality | -- | Technical | 27 |
No chart data available
Stock Overview
Updated DailyKaryopharm Therapeutics Inc. (KPTI) is a leading Healthcare company in the Drug Manufacturers - Specialty & Generic industry, currently trading at $5.80 with a market capitalization of $54.89 million. The stock is in the lower portion of its trading range, demonstrating unrated quality characteristics with a MarketXLS quality score of N/A.
Today's trading session shows KPTI with a volume of 168K shares. The stock opened up 0.17% from yesterday's close of $5.96. Current analyst estimates project earnings of $-11.95 per share for this year, with next year targeting $-6.17.
KPTI demonstrates concerning technical signals based on technical analysis. The company trades on the NGS exchange and operates alongside industry peers including MRK, BMY, ABT, EXEL.
Key investment considerations for KPTI include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 170.2%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 2, 2025 at 06:51 PM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KPTI | $5.80 | -2.7% | 167.93K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Karyopharm Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW